Why Global Medical Device OEMs Are Moving Manufacturing to India
Global medical device OEMs are no longer looking at India only as a sales market. India is becoming a practical manufacturing, assembly, validation and market-entry base for companies that want cost control, supply resilience and access to a large healthcare market. For OEMs, the question is not simply whether India is cheaper. The real question is whether an Indian partner can protect quality, IP, documentation and delivery while helping the product move from design to controlled production.
The strategic reason is supply-chain resilience
Many OEMs want a second manufacturing base that reduces dependence on one country, one supplier or one process route. India is attractive because it combines engineering talent, medical-device demand, growing local manufacturing infrastructure and improving regulatory maturity. For plastic medical devices, consumables, assemblies and cleanroom-packed products, the opportunity is especially strong because tooling, moulding, secondary operations and assembly can be integrated under one program.
India is also a market-access decision
A product made or assembled in India can support a wider go-to-market plan. OEMs can use India for pilot builds, doctor feedback, early usability inputs, local distribution and later export-oriented manufacturing. This is valuable for companies that want to serve India, the Middle East, Africa, Europe or other cost-sensitive markets without building their own factory from day one.
What OEMs should verify before choosing a partner
The right Indian partner should be judged on process control, documentation discipline and ability to manage engineering changes, not only on price. A low quotation without tooling logic, material traceability or validation thinking can create expensive delays later. OEMs should ask for evidence of design-for-manufacture support, mould trial discipline, batch traceability, inspection practices and regulatory awareness.
Clear DFM and tooling review before mould cutting
Documented incoming material and batch traceability
Ability to support pilot builds before full-scale tooling commitment
Cleanroom assembly, packing and sterilisation support where needed
Commercial structure that separates CAPEX, OPEX and transfer pricing clearly
How Medevis Healthtech supports OEMs
Medevis Healthtech works as a single-window CDMO group with Medimals Healthcare for plastic injection moulding, tooling and DFM, Medevis Rubplast for cleanroom assembly and latex-related medical products, and Splendour Medicare for medical textile capability. This structure helps OEMs engage one client-facing partner while execution is handled through specialised operating arms.
Comments